Skip to main content
. 2020 Feb 10;7(2):e16524. doi: 10.2196/16524

Table 1.

Confirmed cessation behaviors over 6-month follow-up.

Cessation behaviors Total sample (N=162) Let’s Talk About Smoking (N=84) National Cancer Institute Education (N=78)
Verified use of cessation treatment, n (%)

Met with doctor to discuss cessation 72 (44.4) 37 (44) 35 (45)

Nicotine replacement therapy 34 (20.9) 18 (21) 16 (21)

Bupropion 7 (4.3) 6 (8) 1 (1)

Varenicline 3 (1.9) 0 (0) 3 (4)

Individual cessation counseling 35 (21.6) 16 (19) 19 (24)

Group cessation counseling 15 (9.3) 7 (8) 8 (10)

Cessation counseling and medication 21 (13.0) 12 (14) 9 (11)

Started any treatment 63 (38.9) 27 (32) 36 (46)
Self-reported or verified use of cessation treatment, n (%)

Met with doctor to discuss cessation 92 (56.8) 44 (56) 48 (57)

Nicotine replacement therapy 52 (32.1) 24 (31) 28 (33)

Bupropion 13 (8.0) 8 (10) 5 (6)

Varenicline 15 (9.3) 7 (9) 8 (10)

Individual cessation counseling 52 (32.1) 25 (32) 27 (32)

Group cessation counseling 25 (15.4) 10 (13) 15 (18)

Cessation counseling and medication 35 (21.6) 17 (22) 18 (231)

Started any treatment 82 (50.6) 34 (44) 48 (57)
Abstinence outcomes, n (%)

Verified abstinence at 6 monthsa 7 (4.3) 1 (1) 6 (8)

Any quit attempt with ≥1 day abstinenceb 61 (37.2) 25 (30) 36 (46)

Any quit attempt with ≥7 days abstinenceb 24 (14.8) 13 (15) 11 (14)

aCalculated from randomized sample.

bCalculated from follow-up sample.